Read more about how transcatheter aortic valve implantation results in a higher risk of mortality and stroke compared with surgical replacement.

What to make of the results remains uncertain, but experts agree that greater vigilance in low-risk patients is warranted.

With careful selection, same-day hospital discharge was found to be feasible and safe in around one-fifth of patients ...

Valve-in-valve (ViV) transcatheter procedures for a failed aortic bioprosthesis are associated with a lower risk of in-hospital mortality compared with a repeat surgical aortic valve replacement, but ...

In patients with symptomatic severe aortic stenosis at intermediate or higher surgical risk, CoreValve or Evolut transcatheter aortic valve implantation (TAVI) was associated with a lower 5-year ...

Medanta-The Medicity in Noida has launched its Structural Heart Interventional Cardiology Programme with the successful ...

COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc. today announced successful results in an additional 5 patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) ...

Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter Aortic Valve Implantation System™ ...

NORRISTOWN, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc., announced today successful 30-day outcomes in the first two patients receiving the Optimum Transcatheter Aortic Valve (Optimum TAV™).

Transcatheter aortic valve implantation (TAVI) has been touted for “revolutionizing the field of cardiology,” as the preferred treatment for most patients over age 70 years with severe aortic stenosis ...

With careful selection, same-day hospital discharge was found to be feasible and safe in around one-fifth of patients undergoing transcatheter aortic valve implantation in a study presented today at ...